Early Pregnancy Sample Collection Study
EPS
Generic Protocol for the Collection of Early Pregnancy Urines
1 other identifier
interventional
4,025
1 country
1
Brief Summary
Female volunteers, wishing to become pregnant will be offered the use of Clearblue ovulation prediction products to help identify their most fertile time and aid conception. Volunteers will provide SPD with a daily urine sample throughout the study period, which will be used for the development and validation of SPD products related to pregnancy and fertility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pregnancy
Started Jan 2012
Longer than P75 for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 11, 2012
CompletedFirst Posted
Study publicly available on registry
April 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedDecember 22, 2017
November 1, 2016
5.2 years
April 11, 2012
December 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Collection of early pregnancy urine samples.
Volunteers who become pregnant during the study will continue to collect daily urine samples until day 60 of the conception cycle.
60 days
Study Arms (1)
sample collection
OTHEROvulation prediction products provided to aid conception
Interventions
Home diagnostics for ovulation prediction will be provided to study volunteers
Eligibility Criteria
You may qualify if:
- Female, age 18-45
- Have menstrual bleeds
- Seeking to become pregnant
- Willing to provide written, informed consent
You may not qualify if:
- Known condition to contra-indicate pregnancy
- Having treatment for infertility.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SPD Development Company Ltd
Bedford, Bedfordshire, MK44 3UP, United Kingdom
Related Publications (2)
Gadsby R, Ivanova D, Trevelyan E, Hutton JL, Johnson S. The onset of nausea and vomiting of pregnancy: a prospective cohort study. BMC Pregnancy Childbirth. 2021 Jan 6;21(1):10. doi: 10.1186/s12884-020-03478-7.
PMID: 33407214DERIVEDJohnson S, Marriott L, Zinaman M. Can apps and calendar methods predict ovulation with accuracy? Curr Med Res Opin. 2018 Sep;34(9):1587-1594. doi: 10.1080/03007995.2018.1475348. Epub 2018 May 25.
PMID: 29749274DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2012
First Posted
April 13, 2012
Study Start
January 1, 2012
Primary Completion
March 1, 2017
Study Completion
September 1, 2017
Last Updated
December 22, 2017
Record last verified: 2016-11